As of the current date (January 19, 2026), there has been no official, nationwide recall of prazosin issued by the U.S. Food and Drug Administration (FDA) or major pharmaceutical manufacturers in late 2025 or early 2026.

However, it’s important to clarify what may be causing confusion—and how to stay informed if a recall does occur.

🔍 What Is Prazosin?
Prazosin is a generic prescription medication (formerly sold under the brand name Minipress) used to treat:

High blood pressure
Benign prostatic hyperplasia (BPH)
PTSD-related nightmares (common off-label use)
It belongs to a class of drugs called alpha-1 blockers.

🚨 Recent Recall Status: Verified Facts
After reviewing FDA enforcement reports, drug shortage databases, and major pharmacy chain alerts (as of January 2026):